Appendix C
Speaker Biographical Sketches
Olusoji Adeyi, M.D., M.B.A., Dr.P.H., is the director of the Health, Nutrition and Population Global Practice at the World Bank Group. He has served as the World Bank’s sector manager for Health, Nutrition and Population in Eastern and Southern Africa, with responsibilities for the institution’s support for policies, strategies, and programs in the sub-region. Dr. Adeyi was founding director of the Affordable Medicines Facility-malaria (AMFm) at the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Formerly coordinator of public health programs at the World Bank, Dr. Adeyi led a number of initiatives on global public health policies and strategies, as well as analyses of the integration of health systems and health interventions. Dr. Adeyi has extensive experience in policies, strategies, and programs for health systems, service delivery, and disease control at the global, regional, and country levels in Africa, Eastern Europe, and Central Asia. He has also had responsibilities with the Federal Ministry of Health in Nigeria, the World Health Organization, the Joint United Nations Programme on HIV/AIDS, and the Harvard T.H. Chan School of Public Health. He has authored research papers and books on service delivery, quality of care, maternal health, health financing, HIV/AIDS, tuberculosis, malaria, and chronic noncommunicable diseases.
Rajesh Anandan, M.Eng., is an intrapreneur, entrepreneur, and growth architect. He is the co-creator of UNICEF Kid Power, the world’s first
wearable-for-good, and co-founder of ULTRA Testing, a high-quality software testing company employing individuals on the autism spectrum.
Mr. Anandan is a senior vice president at the U.S. Fund for UNICEF, where he has led the development of public–private partnerships with corporations, foundations, and academia; modernized the Trick or Treat for UNICEF and UNICEF Tap campaigns; overseen digital platforms and fundraising efforts; and co-led the organization’s strategic planning process. In 2012, he founded UNICEF Ventures, an incubator for new social ventures, and in 2014, launched UNICEF Kid Power and UNICEF Market.
Mr. Anandan began his career at Microsoft as a program manager, and then joined Bain & Company, where he focused on business incubation and growth strategy for technology, media, financial services, health care, and retail clients. For the past decade, he has worked in the impact sector, including setting up and running the Private Sector division at the Global Fund to Fight AIDS, Tuberculosis and Malaria, where he was responsible for large-scale co-investments, access and pricing initiatives, and cause-related marketing campaigns such as (PRODUCT)RED.
Mr. Anandan is a member of the Steering Committee of the UNICEF Global Innovation Center, the Advisory Board of the Asperger’s Syndrome Training and Employment Partnership, the Impact Committee of Unreasonable Capital, and serves as an adviser to a number of social enterprises and technology startups. He grew up in Sri Lanka, has worked in Africa, Asia, Europe, and North America, and has a B.Sc. and an M.Eng. in Computer Science and Electrical Engineering from the Massachusetts Institute of Technology with concentrations in Artificial Intelligence, Systems Dynamics, and Economics.
Rifat Atun, MBBS, M.B.A., is professor of global health systems at the Harvard T.H. Chan School of Public Health, Harvard University, and director of the Global Health Systems Cluster. In 2006–2013, he was professor of International Health Management at Imperial College London, where he led the Health Management Group and remains a visiting professor at the Faculty of Medicine. In 2008–2012, Professor Atun served as a member of the Executive Management Team of the Global Fund to Fight AIDS, Tuberculosis and Malaria in Switzerland as the director of the Strategy, Performance, and Evaluation Cluster. Dr. Atun’s research focuses on global health systems, global health financing, and innovation in health systems. He has published around 200 articles in peer-reviewed journals, including in Lancet, PLoS Medicine, BMJ, Lancet Infectious Diseases, Journal of Infectious Diseases, and the Bulletin of the World Health Organization. Dr. Atun has worked at the UK Department for International Development Health Systems Resource Centre as regional manager for Europe and Central Asia and has acted as a consultant for the World Bank, the
World Health Organization, and other international agencies globally to design, implement, and evaluate health system reforms. Dr. Atun studied medicine at the University of London as a Commonwealth Scholar and subsequently completed his postgraduate medical studies and master’s in business administration degree at the University of London and Imperial College London. He is a Fellow of the Faculty of Public Health of the Royal College of Physicians (UK), a Fellow of the Royal College of General Practitioners (UK), and a Fellow of the Royal College of Physicians (UK).
Simon Bland, M.S., C.B.E., joined the Joint United Nations Programme on HIV/AIDS (UNAIDS) in August 2013 as its director in New York. Prior to joining UNAIDS, he was a senior civil servant in the United Kingdom’s Department for International Development (DFID) and, most recently, headed its Global Funds Department. In this role, he was responsible for the United Kingdom’s policies, programs, financial management, and shareholder relations with Global Funds and Innovative Finance in health and education. He represented the United Kingdom on the Boards of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), the Gavi Alliance, UNITAID, and the Global Partnership for Education. From September 2011 to June 2013, Mr. Bland was chair of the Board of the Global Fund and oversaw a substantial transformation culminating with the introduction of its new funding model and strengthened partnership approach. Mr. Bland’s early background was in marine sciences and natural resources management, later branching out into development economics and management. He has spent most of the past 30 years working in developing countries in Africa, Asia, and the Pacific. He has led DFID country programs in Kenya, Russia, Somalia, and Ukraine, before moving to Geneva to work on global health, education, and humanitarian affairs. Mr. Bland was made a commander of the British Empire in the Queen’s Birthday Honours list in 2013 for service to global health.
Robert C. Bollinger M.D., M.P.H., is a professor of infectious diseases in the Department of Medicine of the Johns Hopkins School of Medicine, with joint appointments in the Department of International Health of the Bloomberg School of Public Health and the Johns Hopkins School of Nursing. He has more than 35 years of experience in international public health, clinical research, and education in a broad range of global health priorities, including HIV/AIDS, malaria, tuberculosis, leprosy, and emerging infections. Dr. Bollinger is engaged in collaborative research projects in Colombia, India, Uganda, and the United States. Dr. Bollinger is director of the Johns Hopkins Center for Clinical Global Health Education (CCGHE), which develops and provides clinical education to health
care providers in resource-limited communities around the world. Under Dr. Bollinger’s leadership, the CCGHE has developed educational and research programs in more than 20 countries, becoming a leader in the development and use of distance learning and mobile health (mHealth) technology in resource-limited settings. Dr. Bollinger’s research interests include identification of the biological and behavioral risk factors for HIV transmission, characterization of the clinical progression and treatment of HIV and related infections, and projects focused on optimizing strategies to improve health care capacity and care delivery in resource-limited settings. Dr. Bollinger has recently been appointed Hopkins director of a new public–private partnership among corporate stakeholders, Johns Hopkins University, and IMEC, a Belgium-based global leader in silicon chip technology, to design and evaluate next generation point-of-care “lab on a chip” diagnostic technologies. Dr. Bollinger has published more than 170 peer-reviewed research publications and 15 book chapters. Dr. Bollinger is also an active clinician/educator who provides and supervises HIV and infectious diseases clinical care in the outpatient and inpatient settings at Johns Hopkins Hospital. Dr. Bollinger has contributed to many public health training programs, expert committees, and consultations in more than 18 countries, as well as serving on the U.S. Presidential Advisory Council on HIV/AIDS. His commitment to health education and research has been recognized by the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award. Dr. Bollinger is board certified in Internal Medicine and Infectious Diseases from the American Board of Internal Medicine, having received internal medicine training at the University of Maryland Medical Systems and a Post-doctoral Fellowship in Infectious Diseases from the Johns Hopkins University School of Medicine. Dr. Bollinger has been on the faculty at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health since 1992.
Katherine Bond, Sc.D., is vice president of International Regulatory Affairs at the U.S. Pharmacopeial Convention (USP). She develops and executes USP’s global regulatory affairs agenda in alignment with strategic organizational objectives and plays a key role in building and sustaining relationships with regulatory agencies and pharmacopeias around the world.
Dr. Bond brings more than 20 years of demonstrated public health leadership experience—in the field and in management—to her role at USP. Dr. Bond arrived at USP from the U.S. Food and Drug Administration, where she served in the Office of International Programs as associate director of Technical Cooperation and Capacity Building before being named director of the Office of Strategy, Partnerships, and Analytics. Prior to public service, Dr. Bond focused her energies on priority public health
issues such as infectious diseases and health systems impacting Southeast Asia and Africa. She worked as associate director of The Rockefeller Foundation’s Asia Regional Office and Africa Regional Office and as deputy director of the Mekong Regional Office of the Program for Appropriate Technology in Health (PATH). Dr. Bond also has held many consultancies and academic appointments—as both lecturer and researcher—at universities in the United States and abroad. She additionally appears as lead or contributing author on a variety of peer-reviewed research papers and technical documents in areas of regulatory systems strengthening, global health security, health systems, and intervention strategies for specific at-risk populations. Dr. Bond earned her Bachelor of Arts degree in Sociology and Anthropology from Swarthmore College and her Doctor of Science degree from the Johns Hopkins Bloomberg School of Public Health.
Jo Ivey Boufford, M.D., is president of The New York Academy of Medicine. Dr. Boufford is professor of public service, health policy, and management at the Robert F. Wagner Graduate School of Public Service and clinical professor of pediatrics at New York University School of Medicine. She served as dean of the Robert F. Wagner Graduate School of Public Service at New York University from June 1997 to November 2002. Prior to that, she served as principal deputy assistant secretary for health in the U.S. Department of Health and Human Services (HHS) from November 1993 to January 1997, and as acting assistant secretary from January 1997 to May 1997. While at HHS, she served as the U.S. representative on the Executive Board of the World Health Organization (WHO) from 1994 to 1997. From May 1991 to September 1993, Dr. Boufford served as director of the King’s Fund College, London, England. The King’s Fund is a royal charity dedicated to the support of health and social services in London and the United Kingdom. She served as president of the New York City Health and Hospitals Corporation (HHC), the largest municipal system in the United States, from December 1985 until October 1989. Dr. Boufford was awarded a Robert Wood Johnson Health Policy Fellowship at the Institute of Medicine in Washington, DC, from 1979 to 1980. She served as a member of the National Council on Graduate Medical Education and the National Advisory Council for the Agency for Healthcare Research and Quality from 1997 to 2002. She currently serves on the boards of the United Hospital Fund, the Primary Care Development Corporation, and Public Health Solutions (formerly MHRA). She was president of the National Association of Schools of Public Affairs and Administration in 2002–2003. She was elected to membership in the National Academy of Medicine in 1992 and is a member of its Executive Council. She is also a member of the National Academies of Sciences, Enginering, and Medicine’s Board on Global Health and Board on African Science Academy
Development. She was elected to serve a second 4-year term as the foreign secretary of the National Academy of Medicine beginning July 1, 2010. She received Honorary Doctorate of Science degree from the State University of New York, Brooklyn, May 1992; New York Medical College, May 2007; Pace University, May 2011; and Toledo University, June 2012. She was elected a Fellow of the National Academy of Public Administration in 2005. She has been a Fellow of The New York Academy of Medicine since 1988 and a Trustee since 2004. Dr. Boufford attended Wellesley College for 2 years and received her B.A. in Psychology magna cum laude from the University of Michigan and her M.D., with distinction, from the University of Michigan Medical School. She is Board Certified in Pediatrics.
Mushtaque Chowdhury, Ph.D., is the vice chair of BRAC, the world’s largest nongovernmental organization. Previously, he was its deputy executive director, founding director of the Research and Evaluation Division, and founding dean of the James P. Grant School of Public Health. Dr. Chowdhury is also a professor of population and family health at the Mailman School of Public Health of Columbia University in New York. During 2009–2012, he worked as the senior adviser to The Rockefeller Foundation, based in Bangkok, Thailand. He also served as a MacArthur Fellow at Harvard University. Dr. Chowdhury holds a Ph.D. from the London School of Hygiene and Tropical Medicine, an M.Sc. from the London School of Economics, and a B.A. (honors) from the University of Dhaka.
Dr. Chowdhury was a coordinator of the United Nations Millennium Task Force on Child Health and Maternal Health, set up by the former Secretary General Kofi Annan. He is a co-recipient of the “Innovator of the Year 2006” award from the Marriott Business School of Brigham Young University in United States, and in 2008, he received the PESON Oration Medal from the Perinatal Society of Nepal. He has a wide interest in development, particularly in the areas of education, public health, poverty eradication, and the environment. Dr. Chowdhury has published more than 150 articles in peer-reviewed international journals, including the International Journal on Education, Lancet, Social Science & Medicine, Scientific American, and the New England Journal of Medicine. One of his recent books is From One to Many: Scaling Up Health Programs in Low Income Countries (co-edited with Richard Cash et al.), published in 2011. He coordinated the recently launched Lancet Series on Bangladesh (http://www.thelancet.com/series/bangladesh). Lancet also published a “profile” celebrating his contributions to global health.
Dr. Chowdhury is a founder of the Bangladesh Education Watch and the Bangladesh Health Watch, two civil society watchdogs on education and health, respectively. He is on the board and committees of several
organizations and initiatives, including the Board of Trustees of BRAC University in Bangladesh and the International Advisory Board of the Centre for Sustainable International Development at the University of Aberdeen in the United Kindgom.
Gary M. Cohen is Executive Vice President and President, Global Health and Development at BD (Becton, Dickinson and Company), a global medical technology company operating in 150 countries with more than 45,000 employees. He joined BD in 1983 and has served as an executive officer since 1996. Mr. Cohen is also acting CEO of GBCHealth and a board director of the Perrigo Company, CDC Foundation and U.S. Fund for UNICEF, and board chair/founder of Together for Girls, a partnership of five United Nations (UN) agencies, the governments of the United States and Canada and other partners to end violence against children, particularly sexual violence against girls. He is a vice chair of the MDG Health Alliance and recently served on the UN Commission on Life Saving Commodities for Women and Children. He is also a member of the UN Secretary General’s Network of Engaged Men Leaders. Mr. Cohen and BD extensively engage in cross-sector collaboration to address unmet health needs globally, including among high disease burden, low resource populations, utilizing various methods such as social investing, CSR and shared value creation. He serves as a speaker and advocate on advancing health and human rights in forums, including the United Nations, World Economic Forum, and Clinton Global Initiative. He has been honored by Medical Education for South African Blacks, B’nai B’rith International, the U.S. Fund for UNICEF, the Nyumbani Home for orphaned HIV-positive children, the American Jewish Committee and the Dikembe Mutombo Foundation. Mr. Cohen holds a B.A. and an M.B.A. from Rutgers University and previously served on the university’s board of trustees.
Bruce Compton, is senior director of international outreach for the Catholic Health Association (CHA) of the United States. He is based in the association’s St. Louis office. Mr. Compton is responsible for assisting and supporting CHA-member organizations in their outreach activities in the developing world. His duties include facilitating collaboration among CHA-member organizations and others, seeking to enhance the impact of international ministries. Additionally, he is responsible for education regarding international outreach issues and encouraging CHA members’ participation in various activities of international ministry. Mr. Compton lived in Haiti from 2000 to 2002 and he continued to work in support of health missions in the developing world after he returned to the United States. He did so in his capacity as founding president and chief executive of the Springfield, Illinois–based Hospital Sisters Mission Outreach,
a ministry organization bringing surplus medical supplies from Midwest hospitals to medical missions in the developing world.
Steve Davis, M.A., J.D., is president and CEO of Program for Appropriate Technology in Health (PATH). As president, he combines his extensive experience as a technology business leader, global health advocate, and social innovator to accelerate great ideas and bring lifesaving solutions to scale. He oversees PATH’s work of driving transformative global health innovation to save and improve lives, reaching 219 million people in 2013. Mr. Davis’s long-standing commitment to human rights and global development grew from his early work on refugee programs and policies, and from his later focus on Chinese politics and law. He has employed that same passion as a leader and strategist for a range of private and nonprofit companies and international organizations, including as CEO of Internet pioneer and global digital media firm Corbis, director of social innovation for McKinsey & Company, and interim CEO of the Infectious Disease Research Institute. Earlier in his career, he practiced law at the international law firm of K&L Gates, with a focus on intellectual property.
Mr. Davis is a member of the Council on Foreign Relations and holds a faculty appointment as a lecturer at the Stanford Graduate School of Business. He currently serves on the boards of InterAction and Global Partnerships and sits on several advisory groups, including the World Economic Forum’s Global Agenda Council on Social Innovation, the Clinton Global Initiative’s Global Health Advisory Board, the Council on Foreign Relation’s Task Force on Non-Infectious Diseases, and Wellcome Trust’s Sustaining Health Dialogue. He previously has served on numerous corporate and nonprofit boards.
Trevor Gunn, Ph.D., is vice president of International Relations for Medtronic, the world’s largest medical technology company. He was formerly the long-time director of the U.S. Department of Commerce’s Business Information Service for the Newly Independent States (BISNIS), the clearinghouse for U.S. government information for doing business in the former Soviet Union. He has served continuously for the past 21 years as adjunct professor at the Center for Eurasian, Russian and East European Studies/School of Foreign Service at Georgetown University. He is a Vicennial Silver Medalist. He received his B.A. from the University of San Francisco and his Ph.D. in International Relations from the London School of Economics in 1992. He has worked with the Chamber of Commerce of Southern Sweden, Dover Elevator Corporation (now ThyssenKrupp of Germany), International Executive Service Corps, and on the staffs of the former San Francisco Mayor and two U.S. senators from California. He sits on the U.S. Department of State’s Advisory Com-
mittee on International Economic Policy; is an official Trade Advisor to the Office of the United States Trade Representative in the “Industry Trade Advisory” system of the U.S. government. Furthermore, he is a member of the Board of Directors for the U.S.–Russia Business Council, the Washington Export Council (Washington, DC), the Board of Advisers of the Washington International Business Council, the Board of Directors of the Executive Council on Diplomacy and the Board of the Center for Citizens Initiatives (San Francisco), and on the Board of Advisors of the University of Wisconsin–Madison’s Center for Business Education and Research (International Business) program. Equally, he is a member of the National Academies of Sciences, Engineering, and Medicine’s Forum on Public–Private Partnerships for Global Health and Safety and is a member of the U.S. Department of Commerce’s District Export Council (Virginia).
A. Reza Jafari, M.B.A, EdS, ABD (Ph.D.), is chairman and CEO of e-Development International, an executive advisory and investment group that promotes, facilitates, and participates in information and communications technology (ICT) initiatives via social entrepreneurship in health care and education in the global markets. Dr. Jafari has spent 35 years in the global information technology (IT) services, telecommunications, media and entertainment, and education industries. He now manages a portfolio of business relationships and interests that include advising established and start-up companies and organizations in Mobile Broadband, eHealth and mHealth, IoT (Internet of Things), big data and cloud services. He currently serves as the chairman of the Board of ITU TELECOM (a United Nations agency) and a commissioner of the Broadband Commission for Sustainable Development. He has served as the chairman of the Board of the India, China, and America Institute; a board member of GSMA, Ltd.; and commissioner of economic development for the state of Maryland. He also served as the chairman and managing director of NeuStar International, and group president of Global Telecom, Media, and Entertainment Industry group and other senior executive positions at Electronic Data Systems (now Hewlett Packard).
Clarion Johnson, M.D., served as Global Medical Director of ExxonMobil Corporation until his retirement in 2013. Currently, Dr. Johnson is a consultant to ExxonMobil, the chair of The Joint Commission’s International and Resource Boards, and a member of the Yale School of Public Health Leadership Council. He serves on several boards, including the Bon Secours Hospital System; the Advisory Board of the Yale School of Public Health; the Board on Global Health of the National Academies of Sciences, Engineering, and Medicine; and co-chairs the Academies’ Forum on Public–Private Partnerships for Global Health and Safety. Dr. Johnson
also has a U.S. Department of Health and Human Services Secretary appointment to the National Institute of Occupational Safety and Health Advisory Board and was a member of the Virginia Governor’s Task Force on Health Reform and co-chair of the Insurance Reform Task Force. He is the past chair of the Virginia Health Care Foundation and the Board of City Lights Charter School in Washington, DC. He served as adviser and lecturer in the Harvard Medical School’s Department of Continuing Education “Global Clinic Course” from 2005 to 2008. In 2013 he received the President’s Award from the Oil and International Petroleum Industry Environment Conservation Association and Oil and Gas Producers for contributions to health and in 2012, he was the recipient of the Society of Petroleum Engineers Award for Health, Safety, Security, Environment and Social Responsibility. In 2011, he received a medal from the French Army’s Institute De Recherche Biomedical for Project Tetrapole: a public–private partnership in malaria research. Dr. Johnson is a graduate of Sarah Lawrence College and member of its Board of Trustees and the Yale School of Medicine. While on active duty in the U.S. Army he also trained as a microwave researcher at the Walter Reed Army Institute of Research. He is board certified in Internal Medicine, Cardiology, and Occupational Medicine.
Andrew Jones has worked extensively in the nonprofit sector in the fields of health care and international development after a number of years working as a hospital manager in the UK National Health Service. As head of partnerships at the Tropical Health and Education Trust (THET), Mr. Jones is responsible for fostering the development of partnerships between the UK health sector and institutions in Africa, Asia, and the Middle East to train and develop health workers, mainly through the Health Partnership Scheme, a $55 million UK government–funded program.
Justin Koester is a senior international relations specialist for Minneapolis-based Medtronic, Inc., the world’s largest independent medical technology company. He has spent the previous 5 years focusing on increasing market access for Medtronic’s innovative medical technologies in emerging markets. Engaging policy makers on market-access barriers and seeking new business opportunities for Medtronic via public–private partnerships and diplomatic engagement. Mr. Koester also currently serves as co-chair of the Non-Communicable Disease (NCD) Roundtable, an independent advocacy organization seeking increased attention and health care policy that strengthens the prevention, diagnosis, treatment, and control of NCDs.
Mr. Koester has experience in advocacy and support for new and enhanced health care policies in more than 150 countries related to medi-
cal device reimbursement and funding, health technology assessment, regulatory approvals and post-market surveillance, procurement, and pricing in regard to medical technology therapies. Previously, he worked for Medtronic as the Latin America clinical research associate, managing more than 22 clinical trials for medical devices. Before Medtronic, he worked for the U.S. Trade and Development Agency on trade evaluations and development impact.
He received a B.A. in Latin American and Hemispheric Studies and International Relations and a B.A. in Economics from George Washington University in 2008.
Margaret E. Kruk, M.D., M.P.H., is an associate professor of global health in the Harvard T.H. Chan School of Public Health’s Department of Global Health and Population. Her research generates evidence for improved health system quality and accountability in low- and middle-income countries. Her work focuses on the intersection of health care delivery and population expectations for health services, with the aim of making health systems more responsive to users. In collaboration with academic colleagues and governments in low-income countries, she studies health care utilization and quality, maternal health, and population preferences for health service delivery. Dr. Kruk is also interested in the development of novel evaluation methods for assessing the effectiveness of complex interventions and health system reforms. She has worked in Ethiopia, Ghana, Kenya, Liberia, Mozambique, Tanzania, Uganda, and Zambia.
Dr. Kruk served as commissioner on Lancet’s Global Health 2035 Commission on Investing in Health and currently serves on the National Academies of Sciences, Engineering, and Medicine’s Committee on Health Systems Strengthening. She is an editor of the Essential Surgery volume of the Disease Control Priorities Project, Third Edition. Prior to joining Harvard, Dr. Kruk was associate professor of health management and policy and director of the Better Health Systems Initiative at the Columbia University Mailman School of Public Health. She was previously policy advisor for health at the United Nations Millennium Project, an advisory body to the UN Secretary General on implementing the Millennium Development Goals. She holds an M.D. from McMaster University and an M.P.H. from Harvard University.
Christophe Longuet, M.D., has been medical director at Fondation Mérieux since March 2007. His responsibilities at the foundation include training and knowledge-sharing activities for health professionals and projects aiming to strengthen health systems and access of the populations to better services. He is a medical doctor, specializing in tropical diseases and HIV/AIDS. He worked for 12 years at Bichat Claude Bernard Hospital,
Paris, where he participated in clinical research in HIV/AIDS and malaria treatment and in medical care of people. He still keeps a clinical practice on a part-time basis in the infectious diseases department of Croix Rousse Hospital, Lyon.
Dr. Longuet has 9 years of experience in the pharmaceutical industry (Merck Sharp & Dohme [MSD]), where he had the responsibility to introduce antiretrovirals in Africa within international partnerships with the World Health Organization and the Joint United Nations Programme on HIV/AIDS. At MSD, he has also been in charge of the humanitarian donation of mectizan for the control of onchocerciasis. Prior to this, he was district medical officer in the Commonwealth of Dominica for the French Cooperation and then practiced internal medicine in Pointe à Pitre University Hospital, Guadeloupe. Dr. Longuet also holds a master’s degree in International Public Health from the Catholic University of Louvain, Belgium, and a postgraduate degree in Health Economics from Paris IXDauphine University.
Myat Htoo Razak, MBBS, M.P.H., Ph.D., has 25 years of experience in clinical services, health policy, epidemiology, HIV/AIDS research and intervention, health systems strengthening, and research capacity building. He is the program director of the Fogarty Global Health Program for Fellows and Scholars, Fulbright-Fogarty Global Health Program, and Fogarty International Trauma and Injury Research Training Program of the Fogarty International Center (FIC) at the National Institutes of Health (NIH). All programs focus on strengthening research capacity and networks for health professionals globally. In addition, Dr. Razak is the FIC/NIH team leader of the Medical Education Partnership Initiative, a $130 million program funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and NIH that aims to improve quantity, quality, and retention of health professionals in Africa.
Before joining NIH in 2009, Dr. Razak held technical leadership positions in the United States, Asia, and Africa, with agencies such as the Centers for Disease Control and Prevention (CDC), the World Health Organization, the Joint United Nations Programme on HIV/AIDS, Family Health International, and Johns Hopkins University. Dr. Razak received his medical degree from the Institute of Medicine in Rangoon, Burma, and an M.P.H. in Health Services Organization and a Ph.D. in Epidemiology from University of California, Los Angeles. Previously, he served as an epidemic intelligence service officer of CDC. Dr. Razak is a member of the Health Systems Strengthening Steering Committee and the Human Resources for Health Working Group of PEPFAR.
Devi Prasad Shetty, MBBS, is chairman and director of Narayana Health. He began his career with the Guys Hospital in London working for the National Health Service, United Kingdom, with whom he was associated till 1989. Subsequently, on his return to India, he started working at the BM Birla Heart Research Centre in Kolkata, where he was involved in the treatment of Mother Teresa. Thereafter, he moved to Bengaluru to commission the Manipal Heart Foundation. He founded a chain of super-specialty hospitals that includes the Rabindranath Tagore International Institute of Cardiac Sciences in Kolkata and Narayana Health City in Bengaluru. Currently, the Narayana Health Group of Hospitals manages 23 hospitals across 14 cities.
Dr. Shetty and his team pioneered the concept of a “Health City,” a 2,000- to 5,000-bed conglomeration of multiple super-specialty hospitals within a single campus. The economies of scale achieved through this health city enable the group to provide affordable health care to thousands. Dr. Shetty was also involved in coining the term “micro-health insurance.” He spearheaded the launch of a health insurance initiative for the farmers of Karnataka in association with the state government.
In addition to his administrative and medical commitments with the Narayana Health Group, Dr. Shetty served on the Board of Governors of the Medical Council of India, an apex body regulating medical education in India. His activities are profiled in several international publications including The Wall Street Journal, which referred to him as the “Henry Ford of cardiac surgery” in a cover page article of Forbes, Fortune, and Business Week. Harvard Business School and Wharton Business School created a case study while reviewing Narayana Health’s unique business model.
Dr. Shetty performed the first open-heart surgery in the world to close a hole in the heart using a microchip camera. He also conducted the first surgery in India using blood vessels of the stomach to bypass blocked arteries of the heart, along with the first dynamic cardiomyoplasty operation in Asia. He was also the first to use the artificial heart in India. He has performed more than 13,000 operations (5,000 on children).
Sally Stansfield, M.D., is a globally recognized leader in public health and development. She brings more than 30 years of expertise in health systems strengthening, with a focus on health information, communication, and technology; data maximization; metrics for evaluation; systems strengthening; and information technology governance. Working with international health organizations, she established and led a global health partnership to strengthen country health information systems in more than 85 countries, mobilizing more than $1 billion in critical new funding.
She has extensive experience working with global health partners and has served as a trusted advisor at the highest levels for many of the world’s leading public health institutions.
Jeffrey L. Sturchio, Ph.D., is president and CEO at Rabin Martin, a global health strategy consulting firm, and former president and CEO of the Global Health Council. Before joining the Council in 2009, Dr. Sturchio was vice president of Corporate Responsibility at Merck & Co., Inc., president of The Merck Company Foundation, and chairman of the U.S. Corporate Council on Africa (CCA), whose 160 member companies represent some 85 percent of total U.S. private sector investment in Africa. While at Merck & Co., Inc., for more than a decade, he was a leader of the company’s global HIV/AIDS policy and was centrally involved in the United Nations/Industry Accelerating Access Initiative established in 2000 to help improve HIV/AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005–2009) and a member of the private-sector delegation to the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria (2002–2008).
He is chairman of the BroadReach Institute for Training and Education and a member of the boards of the Corporate Council on Africa, Friends of the Global Fight Against AIDS, TB and Malaria, and the Museum of AIDS in Africa. Dr. Sturchio is also currently a visiting scholar at the Institute for Applied Economics, Global Health, and the Study of Business Enterprise at The Johns Hopkins University; Senior Associate at the Center for Strategic and International Affairs; a principal of the Modernizing Foreign Assistance Network; a Fellow of the American Association for the Advancement of Science; a member of the Council on Foreign Relations and the Arthur W. Page Society; and an advisor to amfAR, the Clinton Global Initiative, and the NCD (noncommunicable) disease Alliance, among others. He received an A.B. in History from Princeton University and a Ph.D. in the History and Sociology of Science from the University of Pennsylvania. His publications include Noncommunicable Diseases in the Developing World: Addressing Global Gaps in Policy and Research (edited with L. Galambos, Johns Hopkins University Press, 2013).
Katherine Taylor, Ph.D., M.Sc., is the associate director and director of Global Health Training with an appointment in the Biological Sciences Department at the University of Notre Dame. In her current position, she serves as the university liaison for a number of international global health partnerships. She is also actively involved in training and global health education as the director of the Master of Science in Global Health Program. Dr. Taylor earned a B.Sc. from Purdue University, an M.Sc. from the
University of Notre Dame, and a Ph.D. from the Vrije University, Brussels. Her research experience includes 14 years in Kenya, initially employed by the U.S. Centers for Disease Control and Prevention on malaria research projects in collaboration with the U.S. Army and the Kenya Medical Research Institute. The last 10 years in Kenya she worked on the immunology of African trypanosomes in livestock at the International Livestock Research Institute and served as the project leader for Immunology and Vaccine Development. Dr. Taylor left Kenya in 2001 to join the National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases as a program officer. There she developed and led a new Drug Development Section within the Office of Biodefense that funded a portfolio of contracts for the development of new drugs against high-priority biothreats. Dr. Taylor is a past chair of the American Society for Tropical Medicine and Hygiene’s Committee for Global Health and also serves on its Program Committee.
Aye Aye Thwin, M.D., Ph.D., is a physician with a doctorate in public health economics. She has more than 25 years of international experience in health systems and financing reform. From 1991 to 1995, Dr. Thwin served in Bangladesh with the German Agency for Technical Cooperation (GIZ) as an advisor to the National Institute of Population Research and Training, Ministry of Health and Family Welfare. In 1995, she was on the faculty at the Johns Hopkins Bloomberg School of Public Health, and seconded as senior technical advisor to the International Centre for Diarrhea Disease Research, Bangladesh. For the next 4 years, she led Johns Hopkins University’s research program in Bangladesh on health financing, analysis of health and population policy, and urban poverty. She also served as an advisor to the Ministry on specific structural and organizational reforms. In 1999, she joined the World Health Organization as health financing and sector management advisor to the Ministry of Health, Cambodia, serving as team leader for health systems strengthening, policy and budgetary reforms, and donor coordination. She joined the U.S. Agency for International Development (USAID) in 2003, served for 1 year at the Bureau of Global Health in Washington, DC, and was later assigned to the Philippines as the chief of the Office of Health from 2004 to 2009. In 2009, she moved to USAID’s Regional Mission for Asia as the director of the Office of Public Health. In August 2014, Dr. Thwin was assigned as senior health advisor at USAID headquarters responsible for a range of strategic initiatives on health systems strengthening and financing. Dr. Thwin has a medical degree from the Institute of Medicine, Burma, a masters in public health from Mahidol University, Thailand, and a Doctor of Science degree from the Johns Hopkins Bloomberg School of Public Health.
Jeanette Vega Morales, M.D., Ph.D., is the director of the national Chilean Public Health Insurance Agency (FONASA) since March 2014. Dr. Vega has more than 20 years of experience in international health. Her areas of expertise include social determinants of health, health equity, and health systems. Prior to being appointed as director of FONASA by President Michelle Bachelet, Dr. Vega served as managing director of health at the Rockefeller Foundation. She was vice minister of health in Chile, between 2008 and 2010, leading the country’s 13-step agenda for equity in health. Before that, she served as a director at the World Health Organization in Geneva, where she led the equity in health agenda, looking at the social determinants of health and health systems. Dr. Vega started her career as a medical doctor in Chile specializing in family medicine. She has a master’s degree in public health from the Universidad de Chile and a Ph.D. in public health from the University of Illinois at Chicago.
